Biokraft International AB reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 118.83 million compared to SEK 94.22 million a year ago. Revenue was SEK 131.07 million compared to SEK 100.39 million a year ago. Net loss was SEK 31.16 million compared to SEK 15.28 million a year ago. Basic loss per share from continuing operations was SEK 0.71 compared to SEK 0.53 a year ago.
For the nine months, sales was SEK 346.32 million compared to SEK 290.09 million a year ago. Revenue was SEK 396.3 million compared to SEK 299.81 million a year ago. Net loss was SEK 101.87 million compared to SEK 66.73 million a year ago. Basic loss per share from continuing operations was SEK 2.34 compared to SEK 2.33 a year ago.